Abstract
Many patients with end-stage renal disease have now been maintained for 5 years or more with continuous ambulatory peritoneal dialysis (CAPD). Viewed initially as an experimental alternative to be used only when hemodialysis was not feasible, CAPD is now seen as the treatment of choice in an increasing number of situations. CAPD is suitable for self-care. The main concern in the early years - peritonitis - is now less frightening and less frequent (one episode occurring every 18 patient-months as compared with every 8 initially), and this has allowed chronic complications of CAPD, such as malnutrition and loss of the peritoneum's capacity for ultrafiltration, to come to light. As would be expected, among patients of advanced age and those who have heart disease or diabetes, survival rates tend to be lower than among other CAPD patients. However, hypertension seems to be more easily controlled, pre-existing anemia can be significantly ameliorated, and young children grow more normally than they do with hemodialysis. Diabetes-related changes in vision stabilize in most CAPD patients, and control of the blood glucose level is good; insulin is administered intraperitoneally. CAPD is thus showing itself to be a feasible form of long-term treatment for end-stage renal disease.
| Original language | English |
|---|---|
| Pages (from-to) | 699-707 |
| Number of pages | 9 |
| Journal | Canadian Medical Association Journal |
| Volume | 130 |
| Issue number | 6 |
| Publication status | Published - 1984 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Continuous ambulatory peritoneal dialysis : No longer experimental. / Wu, G.; Khanna, R.; Vas, S.; Digenis, G.; Oreopoulos, D. G.
In: Canadian Medical Association Journal, Vol. 130, No. 6, 1984, p. 699-707.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Continuous ambulatory peritoneal dialysis
T2 - No longer experimental
AU - Wu, G.
AU - Khanna, R.
AU - Vas, S.
AU - Digenis, G.
AU - Oreopoulos, D. G.
PY - 1984
Y1 - 1984
N2 - Many patients with end-stage renal disease have now been maintained for 5 years or more with continuous ambulatory peritoneal dialysis (CAPD). Viewed initially as an experimental alternative to be used only when hemodialysis was not feasible, CAPD is now seen as the treatment of choice in an increasing number of situations. CAPD is suitable for self-care. The main concern in the early years - peritonitis - is now less frightening and less frequent (one episode occurring every 18 patient-months as compared with every 8 initially), and this has allowed chronic complications of CAPD, such as malnutrition and loss of the peritoneum's capacity for ultrafiltration, to come to light. As would be expected, among patients of advanced age and those who have heart disease or diabetes, survival rates tend to be lower than among other CAPD patients. However, hypertension seems to be more easily controlled, pre-existing anemia can be significantly ameliorated, and young children grow more normally than they do with hemodialysis. Diabetes-related changes in vision stabilize in most CAPD patients, and control of the blood glucose level is good; insulin is administered intraperitoneally. CAPD is thus showing itself to be a feasible form of long-term treatment for end-stage renal disease.
AB - Many patients with end-stage renal disease have now been maintained for 5 years or more with continuous ambulatory peritoneal dialysis (CAPD). Viewed initially as an experimental alternative to be used only when hemodialysis was not feasible, CAPD is now seen as the treatment of choice in an increasing number of situations. CAPD is suitable for self-care. The main concern in the early years - peritonitis - is now less frightening and less frequent (one episode occurring every 18 patient-months as compared with every 8 initially), and this has allowed chronic complications of CAPD, such as malnutrition and loss of the peritoneum's capacity for ultrafiltration, to come to light. As would be expected, among patients of advanced age and those who have heart disease or diabetes, survival rates tend to be lower than among other CAPD patients. However, hypertension seems to be more easily controlled, pre-existing anemia can be significantly ameliorated, and young children grow more normally than they do with hemodialysis. Diabetes-related changes in vision stabilize in most CAPD patients, and control of the blood glucose level is good; insulin is administered intraperitoneally. CAPD is thus showing itself to be a feasible form of long-term treatment for end-stage renal disease.
UR - http://www.scopus.com/inward/record.url?scp=0021355199&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021355199&partnerID=8YFLogxK
M3 - Article
C2 - 6697277
AN - SCOPUS:0021355199
VL - 130
SP - 699
EP - 707
JO - CMAJ
JF - CMAJ
SN - 0008-4409
IS - 6
ER -